跳至主要内容
临床试验/CTRI/2022/11/047072
CTRI/2022/11/047072尚未招募未知

Incidence of polymyxin B, tigecycline and minocycline resistant Acinetobacter baumannii causing ventilator-associated pneumonia or hospital acquired pneumonia among intensive care unit patients and determination of risk factors for adverse outcomes.

Souvik Chaudhuri0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients aged 18-90 years and newly diagnosed VAP or HAP.
  • 2.Clinical suspicion of VAP with the following criteria â?? More than 48 hours of endotracheal intubation and ventilation, chest x-ray showing new, persisting, progressive chest infiltrates, clinical symptoms of fever, leucopenia ( <=4000/µL or >=12,000/µL), new onset purulent sputum, increased oxygen requirement, worsening gas exchange, temperature >38°C or 100.4°F.
  • 3.HAP contracted in a patient with at least 48 hours of hospital stay.

排除标准

  • Pediatric age group < 18 years of age.
  • Patients who are not intubated and not on invasive mechanical ventilation.
  • Patients with < 48 hours of hospitalization.

研究者

发起方
Souvik Chaudhuri

相似试验